Screening for Lung Cancer in the HIV Patient
The study design is that of a prospective cohort study in which 200 smoking participants
will be recruited from an existing HIV-seropositive cohort of 800 patients (the Human Oral
Papillomavirus Etiology (HOPE) Study). Participants will be enrolled from the Johns Hopkins
HIV (Moore) Clinic and the resources of the Johns Hopkins Adult Outpatient General Clinical
Research Center (GCRC) and pilot project funding from the Lung Cancer SPORE will be utilized
to fund the costs of the CT scans. An interdisciplinary team with expertise in
HIV-associated malignancy, CT screening, lung cancer surgery, HIV infection, epidemiology
and biostatistics has been assembled to test the hypothesis by accomplishing the following
Specific Aims:
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Stage distribution of HIV-seropositive patients
To determine differences in stage distribution of HIV-seropositive patients at lung cancer diagnosis between those who are screened by spiral CT and historic controls.
Day 1
No
Malcolm Brock, MD
Principal Investigator
Johns Hopkins University
United States: Institutional Review Board
J0491
NCT01748136
January 2006
September 2011
Name | Location |
---|